Terns Pharmaceuticals Inc (NASDAQ: TERN) – Not A Clear Buying Opportunity?
Terns Pharmaceuticals Inc (TERN) concluded trading on Wednesday at a closing price of $7.08, with 4.72 million shares of worth about $33.41 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3.06% during that period and on December 04, 2024 the price saw a […]
